Trial intelligence / Profile preview

ASPEN: Ambisome Pharmacokinetics in Obese Bariatric Surgery Patients

2014-003306-33Phase 4Completed

Sponsor
Radboud University Medical Center
Start
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of amphotericin b in mycoses and invasive mycoses (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Pharmacokinetic parameters after single intravenous dose. Started Dec 2014; status: completed.

02

Drugs

amphotericin b
03

Conditions

mycosesinvasive mycoses

Beyond the preview

Go deeper on 2014-003306-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-003306-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call